Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2025
Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors
Ciara M Kelly, Martina Bradic, Sara Saunds, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
Sujana Movva, Kenneth Seier, Martina Bradic, et al.
JCO Precision Oncology
|
April 22, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma
Samuel L Cytryn, Raktim Borpatragohain, Karmelina Charalambous, et al.
The Journal of Chemical Physics
|
March 12, 2024
Wave packet dynamics and control in excited states of molecular nitrogen
Mizuho Fushitani, Hikaru Fujise, Akiyoshi Hishikawa, et al.
The Journal of Chemical Physics
|
April 16, 2021
Time-resolved photoelectron imaging of complex resonances in molecular nitrogen
Mizuho Fushitani, Stephen T Pratt, Daehyun You, et al.
Nature Communications
|
November 25, 2021
Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights
Olusegun Isaac Alatise, Gregory C Knapp, Avinash Sharma, et al.
JAMA
|
September 6, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
Diana Mandelker, Liying Zhang, Yelena Kemel, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature Medicine
|
March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Wungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Cancer Cell
|
April 19, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors
Chaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2025
Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors
Ciara M Kelly, Martina Bradic, Sara Saunds, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
Sujana Movva, Kenneth Seier, Martina Bradic, et al.
JCO Precision Oncology
|
April 22, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma
Samuel L Cytryn, Raktim Borpatragohain, Karmelina Charalambous, et al.
The Journal of Chemical Physics
|
March 12, 2024
Wave packet dynamics and control in excited states of molecular nitrogen
Mizuho Fushitani, Hikaru Fujise, Akiyoshi Hishikawa, et al.
The Journal of Chemical Physics
|
April 16, 2021
Time-resolved photoelectron imaging of complex resonances in molecular nitrogen
Mizuho Fushitani, Stephen T Pratt, Daehyun You, et al.
Nature Communications
|
November 25, 2021
Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights
Olusegun Isaac Alatise, Gregory C Knapp, Avinash Sharma, et al.
JAMA
|
September 6, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
Diana Mandelker, Liying Zhang, Yelena Kemel, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature Medicine
|
March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Wungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Cancer Cell
|
April 19, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors
Chaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Page
of 10